We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
UBM | LSE:UBM | London | Ordinary Share | JE00BD9WR069 | ORD 11.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,080.00 | 1,074.00 | 1,076.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/6/2018 08:02 | So, farewell then. It's all done. I note those electing for extra cash will get it in full and those electing for extra shares will be scaled back 71%. Has to be bullish. | grahamite2 | |
06/6/2018 11:41 | Looks correct. I was over £1000 better off, when I checked the other day, taking the extra shares option. No stopping INF/UBM at the moment. | patientcapital | |
05/6/2018 10:53 | No doubt you've all received your corporate action messages over the last two days are making your selections. Having read the document last night, I've done some rough calculations on value when the deal is completed. This is new territory for me so please feel free to critique my numbers to get a fair value comparison please? For ease of calcs let's assume I have 1000 UBM shares currently worth £10,460.In return I'll be getting 1086 Informa shares currently worth 8709.72 (£8.02 per share) and £1630 in cash. Giving me total value of £10,339.72.In addition I'll be getting £180 in final div from UBM and £149.40 div from Informa. Add that to the £10,339.72 from above and I get £10,624.62 (£8709 in shares and £1959.40 in cash) in return for my current holding worth £10,460.Is that right (given current SPs)? | villarich | |
05/6/2018 05:33 | 31 May 2018 The Boards of Informa (“Informa̶ Good news. We should have our cash and new shares by the end of the month. | grahamite2 | |
18/4/2018 14:03 | Good heavens! What was that about? | grahamite2 | |
18/4/2018 14:02 | Hope you get it - maybe you'll get my stock I don't want! | grahamite2 | |
17/4/2018 07:05 | The form to request a variation from the standard allotment says the cut off date will be announced by RNS and on the website - but there is nothing as yet. I'm hoping it's not too late as I only put mine in yesterday, owing to illness. I've asked for about 1/4 of mine to be paid all cash. | grahamite2 | |
22/3/2018 17:32 | Mine are in ISA so haven't seen the documents. Still minded to take shares as far as permitted. Price holding very well with wider markets falling. I see they are getting upset again on the other side. Roll on withdrawal :) | patientcapital | |
16/3/2018 07:15 | PC, now the documentation has arrived are you still thinking of going for additional shares? I'm contemplating going the other way, cash for about 1/3 of my holding (to avoid CGT issues). Nothing against these companies but the market as a whole seems a bit elevated to me and the WPP situation isn't encouraging. | grahamite2 | |
14/3/2018 14:33 | 1 o'clock RNS - the scheme document is on the informa website. I dare say most of us can wait for tomorrow's post! | grahamite2 | |
14/3/2018 10:17 | A bit surprised there's no RNS as yet. | grahamite2 | |
13/3/2018 16:02 | Looking forward to tomorrow. | grahamite2 | |
28/2/2018 14:23 | Pretty solid. Madhouse elsewhere again I see. | patientcapital | |
28/2/2018 10:12 | Excellent RNS. Good results for both companies and a timetable at last: The expected timetable for the recommended offer is set out below: 14 March 2018 Publication of Circular, Prospectus and Scheme Document -------------- -------------------- 17 April 2018 Shareholder meetings and vote -------------- -------------------- 20 April 2018 Proposed record date for final dividends -------------- -------------------- Q2 2018 Anticipated completion date in Q2 2018 -------------- -------------------- | grahamite2 | |
27/2/2018 14:56 | But does Friday's Rule 2.9 announcement mean something is going to happen pretty soon? | grahamite2 | |
27/2/2018 14:53 | It's too quiet, I tells ya! I don't like it! | grahamite2 | |
12/2/2018 10:09 | Not much of a bounce here or at Informa. I wonder whether that will affect the cash element of the deal. | grahamite2 | |
09/2/2018 13:21 | Perhaps not. | grahamite2 | |
08/2/2018 13:47 | Any thoughts? | grahamite2 | |
07/2/2018 12:39 | I see the latest document clearly states (on page 1) that the scheme document will be sent out in due course. My mistake. Anyway, I wonder if anyone can help me with a few questions? 1. We have all seen terse RNSs saying an approach had been received and might or might not develop into an offer. How often does a company put out a multi page document about a "possible" offer? 2. How often is there a follow-up multi page document the very next day? 3. How often are full details of every last aspect of an offer sent out without it being a prospectus or scheme document and therefore without voting forms etc? If this were AIM I'd find this all very concerning. It's not, of course, but I still find it pretty odd. | grahamite2 | |
02/2/2018 19:45 | There was also the special dividend 18 months ago - I had forgotten about that but turned it up on checking the dividend histories of both companies. | grahamite2 | |
02/2/2018 19:05 | PC . your post elsewhere: yes, there was a significant return of cash, but it wasn't all that recently - a few years ago, I think. If you're applying for extra INF shares, presumably that means you have seen the scheme document. Is it available online, or just in the documents recently posted out? | grahamite2 | |
02/2/2018 18:36 | Answered on other thread in among all the commies ! | patientcapital | |
02/2/2018 15:34 | 163p a share plus 18p plus 13.8p in dividends plus 1.083 shares in new Informa. I'd like to see the mix and match opportunities but cannot find the scheme document. | grahamite2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions